U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report: ~~May~~ June 2527, ~~2006~~2007

JURAK CORPORATION WORLD WIDE, INC.
PHYTOLABS, INC.
(Exact Name of Small Business Issuer as Specified in its Charter)
MINNESOTA
(State or other Jurisdiction as Specified in Charter)
333-61801		88-0407679
(Commission file number)		(I.R.S. Employer Identification No.)
1181 Grier Drive, Suite C Las Vegas, Nevada 89119-3746
(Address of Principal Executive Offices)
702.914.9688
(Issuer's telephone number)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

	o		Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	o		Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
	o		Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
	o		Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Section 3.8 ~~Securities~~- ~~and~~Other ~~Trading Markets~~Events

Item 38.0201 ~~Recent~~Other ~~Sales of Unregistered Securities~~Events

~~Pursuant~~On toJune a27, ~~Resolution~~2007, of the Board of Directors, ~~and~~authorized inthe ~~agreement~~issuance ~~with~~of 500,000 ~~certain~~options ~~debtors~~to purchase shares of ~~the~~its ~~Company~~common stock at $0.50 per share to Mr. David Wood, the ~~Company~~Chief ~~has~~Executive ~~authorized~~Officer of its wholly-owned subsidiary, Phytolabs Solutions, Inc. The options will be vested at the ~~issuance~~rate of 125,000 shares ofevery six ~~the~~months, ~~Company's~~beginning ~~common~~on ~~stock~~the indate ~~consideration~~of hire of ~~outstanding~~Mr. ~~debt~~Wood. ~~owed~~Every six months following the hire date, an additional option to ~~those~~purchase ~~certain~~125,000 ~~debtors~~shares will vest so long as Mr. Wood retains a position as an officer of Phytolabs, Inc. Options will expire six months from the vested date.

The ~~Company~~Board ~~issued~~also 18authorized the issuance of upt to 2,~~788~~000,~~675~~000 options to purchase shares of ~~restricted~~the Company's common stock at $0.0250 per share. toThe ~~152581~~options may ~~Canada~~be ~~Ltd.~~issued at the discretion of the CEOto an officer, ~~which~~director, ~~was~~employee ~~equal~~or consultant toof the ~~debt~~Consultant ~~owed~~as the CEO deems necessary, under certain exlusions. Options must be exercised within five years of grant date, unless otherwise extended by the Board of Directors or unless grantee ceases to ~~that~~be ~~company~~an officers, director, employee or consultant of the Company.

The Company issued 20,182,413 shares of restricted common stock at $0.02 per share to Anthony Carl Jurak, which was equal to the debt owed to him.

The Company issued 27,595,130 shares of restricted common stock to Jurak Holdings Limited at the rate of $0.02 per share, which was equal to the debt owed to Jurak Holdings Limited.

The Company issued 6,504,360 shares of restricted common stock to Roger Theriault at the rate of $0.02 per share, which was equal to the debt owed to him.

The Board of Directors approved such stock issuance on May 25, 2006.

SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

	Jurak Corporation World Wide, Inc.
	Phytolabs, Inc.
Date: June 15, 2006	By:		/s/ Anthony C. Jurak
Date: July 2, 2007	By:
		/s/ Anthony C. Jurak
		Anthony C. Jurak Chief Executive Officer

Filing Compare · LIFEQUEST WORLD CORP.